Human involucrin (hINV) is a keratinocyte protein that is expressed in the suprabasal compartment of the epidermis and other stratifying surface epithelia. Involucrin gene expression is initiated early in the dierentiation process and is maintained until terminal cell death. The distal regulatory region (DRR) is a segment of the hINV promoter (nucleotides 72473/ 71953) that accurately recapitulates the normal pattern of suprabasal (spinous and granular layer) expression in transgenic mouse epithelia. To identify sequences that mediate expression at speci®c stages of dierentiation, we divided the DRR into two segments, a 376 nucleotide upstream region (DRR 72473/72100 ) and a 147 nucleotide downstream region (DRR 72100/71953 ), and evaluated the ability of these sequences to drive expression in transgenic mice. The DRR 72473/72100 segment drives expression at a level comparable to that observed for the DRR, but expression is restricted to the upper granular layers (i.e., no spinous layer expression). In contrast, the DRR 72100/71953 segment does not drive expression. However, reassembling the DRR restores the complete range of expression. These results suggest that two distinct, spatially-separate elements are required to specify the complete dierentiation-dependent program of involucrin gene expression. To identify speci®c transcription factor binding sites involved in this regulation, we mutated an activator protein-1 binding site, AP1-5, located within DRR 72473/-2100 segment. This site binds AP1 transcription factors present in mouse epidermal extracts, and its mutation eliminates appropriate hINV expression. This result suggests that AP1 factors participate as components of a multicomponent transcription factor complex that is required for regulation.
Introduction
The major cell type, and the cell type responsible for the morphological characteristics of the epidermis, is the epidermal keratinocyte (Green, 1980) . Basal keratinocytes give rise to cells that dierentiate to produce the suprabasal epidermal layers. This involves a highly coordinated series of changes in cell morphology and biochemistry (Eckert et al., 1997a; Green, 1980) . The terminal dierentiated cell, or corneocyte, is a¯attened dead cell that consists of a network of cytokeratin ®laments surrounded by an insoluble envelope of heavily crosslinked protein. The envelope precursors and transglutaminase, the enzyme activity responsible for assembly of the envelope (Kim et al., 1995; Steinert, 1995; Thacher and Rice, 1985; Rice and Green, 1979) , must be expressed at the correct time and level during the dierentiation process for proper envelope formation. Involucrin, an early marker of keratinocyte dierentiation, and a component of the corni®ed envelope, is speci®cally expressed in the suprabasal layers of the epidermis Crish et al., 1993; Murphy et al., 1984) . It accumulates in the spinous and granular layers as a non-crosslinked precursor and becomes covalently crosslinked to other proteins and lipids to form the corni®ed envelope scaolding during the ®nal stages of keratinocyte dierentiation (Steinert and Marekov, 1997; Rice and Green, 1977) .
Previous studies in cultured keratinocytes indicate that the distal regulatory region (DRR, nucleotides 72473/71953) (Banks et al., 1998 (Banks et al., , 1999 accounts for one-half of the activity of the hINV promoter . This region contains weak and strong activator elements (Banks et al., 1998) . The weak activator element enhances the activity of the strong activator element. The strong activator element, nucleotides 72140/72088, plays a key role in regulation of hINV gene expression. This region encodes an AP1 (AP1-5) binding site. AP1 factors junB, junD and Fra-1 interact with the AP1-5 binding site (Banks et al., 1998; . Mutation of the AP1-5 site results in a complete loss of promoter activity when the isolated distal regulatory region is tested in cultured human epidermal keratinocytes (Banks et al., 1998) .
hINV promoter function has also been studied in transgenic mice. Transgenic studies indicate that the full-length involucrin promoter drives tissue-speci®c and dierentiation-appropriate expression in surface epithelial cells Carroll et al., 1993) , and show that this expression pattern can be replicated by the isolated DRR . However, no knowledge is available regarding speci®c DRR regions that function to drive expression in particular epidermal layers, nor whether particular DNA binding sites are important in this context. Our present studies provide evidence that the DRR contains discrete, spatially distinct, DNA sequence elements that are required for expression at speci®c stages during epidermal dierentiation. We further identify AP1 factors as part of this regulatory complex.
Results

Evidence for spatially separated regulatory regions
Our previous studies show that the hINV distal regulatory region (DRR) is sucient to drive tissuespeci®c and dierentiation-appropriate gene expression in mouse surface epithelia . A goal of the present study is to identify speci®c regions within the DRR that are important for expression at various stages during dierentiation. In these studies, as previously reported , we use human involucrin as our reporter gene . This approach avoids problems associated with dierences in turnover rate of involucrin as compared to other possible reporter proteins, such as bgalactosidase or luciferase, in epidermis. We began by testing the constructs shown in Figure 1a . The DRR-P3.4B construct encodes the complete DRR segment linked to the minimal hINV promoter. DRR 72473/ 72100 -P3.4B encodes nucleotides derived from the upstream end of the DRR, and DRR 72100/71953 -P3.4B encodes the nucleotides derived from the downstream end of the DRR. P3.4B encodes the hINV minimal promoter. In Figure 1 , we monitor expression of these constructs in transgenic mouse epidermis. The P3.4B construct, which encodes the minimal hINV promoter, does not drive expression in epidermis. The three lines encoding the DRR 72473/72100 -P3.4B construct express hINV at levels comparable to that observed for DRR-P3.4B ( Figure 1b) . As expected, no expression was detected in non-transgenic (NT) mice. In contrast to the expression observed for DRR 72473/72100 , no expression was observed in each of the three DRR 72100/71953 transgenic lines ( Figure  1c ).
We next utilized immunohistology to compare the pattern of expression of the DRR, DRR 72473/72100 , and DRR 72100/71953 constructs during dierentiation. Footpad is a tissue useful for histological study, Figure 1 The hINV DRR region ± multiple elements control dierentiation-appropriate expression. (a) Construct P3.4B encodes the hINV minimal promoter. The arrow encompasses the hINV gene transcribed region including the shaded small and large rectangles denoting, respectively, the ®rst and second exons. The scale at the top is in kilobases. In the other constructs, segments of the DRR (open boxes) are cloned adjacent the hINV minimal promoter. The shaded circle and box over the DRR indicate, respectively, the AP1-5 and Sp1 sites (Banks et al., 1998 (Banks et al., , 1999 . Nucleotide positions de®ning each DRR segment are presented relative to the transcription start site Eckert and Green, 1986) . (b) To detect hINV transgene expression, equivalent quantities of epidermal total cell extract, prepared from non-transgenic (NT) animals or P3.4B (line 10), DRR-P3.4B (line 31), or DRR 72473/72100 -P3.4B (lines 4, 9, 14) transgenic animals was electrophoresed on a 6% polyacrylamide denaturing and reducing gel, transferred to nitrocellulose, and hINV protein was detected using an hINV-speci®c antibody . The lane marked rhINV contains recombinant human involucrin, electrophoresed as a standard. (c) The analysis is identical to that described in panel B, except that hINV expression was monitored in mice expressing the DRR 72100/71953 -P3.4B transgene (lines 23, 24, 35) because the multiple layers make it easy to visualize dierentiation-dependent expression. As shown in Figure 2 , the intact DRR construct is expressed in all except the most basal footpad layers ± a pattern of expression identical to that of the full-length promoter (see Crish et al. (1993) ). In contrast, the DRR 72473/ 72100 drives expression only in the top few layers. As expected based on the immunoblot results presented in Figure 1 , the DRR 72100/71953 does not drive any histologically detectable expression.
Role of the AP1-5 site
The above studies indicate that sites required for dierentiation-appropriate expression are present at spatially distinct locations within the DRR. A major goal is to identify speci®c elements responsible for this regulation. One site that is required for appropriate hINV promoter activity in cultured keratinocytes is an AP1 site, AP1-5, located within the DRR (Banks et al., 1998 (Banks et al., , 1999 Crish et al., 1998; . To determine whether this site is important for in vivo regulation, we generated and tested transgenes lacking a functional AP1-5 site ( Figure 3a ). Construct H6B includes the full-length (2473 nucleotide) promoter . In DRR-P3.4B, the 520 bp distal regulatory region, shown as an open box, is cloned adjacent the minimal promoter. Parallel constructs lacking a functional AP1.5 site, H6B(AP1 ± 5 mm) and DRR-P3.4B(AP1 ± 5 mm), were constructed encoding the mutant sequence (underlined in Figure 3b ).
We examined the ability of these constructs to drive expression in footpad epidermis. As shown in Figure 4a , H6B directs expression to the suprabasal (spinous and granular) footpad layers and DRR-P3.4B produces an essentially identical pattern of . In H6B(AP1 ± 5 mm) and DRR-P3.4B(AP1 ± 5 mm) the AP1-5 site is inactivated by mutation. The open rectangle depicts the hINV promoter distal regulatory region (DRR, nucleotides 72473/71953). The arrows encompass the transcribed region including the shaded small and large rectangles denoting, respectively, the ®rst and second exons. The shaded circle and box over the DRR indicate, respectively, the AP1-5 and Sp1 sites (Banks et al., 1998 (Banks et al., , 1999 . Distances, in kilobases, are indicated as positive downstream and negative upstream of the transcription start site. (b) Shows the sequence of the hINV promoter AP1-5 5'TGAGTCAG-3' and Sp1 5'-GGGCGGG-3' sites and surrounding sequence. The altered nucleotides in the mutant AP1-5 site are underlined expression. However, expression is lost when AP1-5 is mutated in the context of the isolated DRR, DRR-P3.4B(AP1 ± 5 mm), or in the context of the fulllength promoter, H6B(AP1 ± 5 mm). This loss of expression is con®rmed by immunoblot (Figure 4b ). Thus, mutation of AP1-5, either in the context of the full-length promoter or in the isolated DRR, markedly reduces hINV expression in footpad epidermis.
AP1-5 is required for expression in esophagus and cervix
Involucrin is known to be expressed in other stratifying surface epithelia (Murphy et al., 1984; Banks-Schlegel and Green, 1981; Rice and Green, 1979) . To determine whether AP1-5 site is required for hINV expression in these tissues, we measured hINV levels in esophagus and cervix. As shown in Figure 5 , both H6B and DRR drive appropriate suprabasal expression in esophagus ( Figure 5a ) and cervix ( Figure 5b ). In contrast, mutation of the AP1-5 site, in either the DRR or full-length promoter contexts, reduces hINV expression in both tissues.
Mutation of AP1-5 results in reduced hINV protein levels
To con®rm the immunohistological data and compare the level of hINV expression between mutant and intact constructs, we prepared tissue extracts from footpad epidermis, back epidermis, and esophagus, and measured hINV levels by immunoblot. As displayed in Figure 6 , H6B and DRR-P3.4B, which contain the intact AP1-5 site (+), produce high-level hINV expression in each of these surface epithelia. In contrast, markedly reduced expression is observed in mice harboring the AP1-5 site mutant constructs (7). Although the level of expression is markedly reduced in these mice, the gene is not completely o. This is in contrast to the complete lack of expression in mice containing construct P3.4B, the minimal promoter construct (not shown) .
In previous reports, we described hINV transgene expression in the epithelia lining the proximal convoluted tubules of the kidney . This expression serves as a marker for integrity of the transgene, as transgene-dependent expression is observed in kidney independent of surface epithelial cell expression. As shown in Figure 6 , kidney expression is observed for all of the constructs, whether the AP1-5 site is intact or mutated. The fact that the level of expression is maintained in the kidney argues that the reduced expression in the epithelia of AP1 ± 5 mm mice is not due to inappropriate integration and/or rearrangement of the transgene. These results support the conclusion that the AP1-5 site is required for appropriate hINV expression in surface epithelia. , DRR or DRR(AP1 ± 5 mm) transgenes were ®xed, sectioned, and stained sequentially with hINVspeci®c antibody and horseradish peroxidase-conjugated secondary antibody. Control sections, prepared in the absence of primary antibody, were not stained (not shown). A similar pattern of staining was observed for three independent transgenic lines for each construct. EPI indicates the area of the section that encompasses living epidermis. (b) Immunoblot detection of hINV in transgenic mice. Equivalent quantities of epidermal total cell extract, prepared from non-transgenic H6B, H6B(AP1 ± 5 mm), DRR, and DRR(AP1 ± 5 mm) animals was electrophoresed on an 6% polyacrylamide denaturing and reducing gel, transferred to nitrocellulose, and hINV protein was detected using an hINV-speci®c antibody . The lane marked rhINV contains recombinant human involucrin, electrophoresed as a standard
Interaction of AP1 factors with the DRR AP1-5 site Finally, we used gel mobility shift analysis to con®rm AP1 factor binding at the AP1-5 site. As shown in Figure 7a , incubation of mouse epidermal nuclear extracts with the 32 P-AP1-5, an oligonucleotide that encodes the AP1-5 site and¯anking sequence, results in the appearance of several prominent shifted bands. Incubation in the presence of a 10-or 100-fold molar excess of AP1-5 oligonucleotide speci®cally eliminates several bands. No competition is observed when competition is with a non-speci®c oligonucleotide. We next performed gel mobility supershift experiments to identify speci®c AP1 factors present in the shifted complex. As shown in Figure 7b , our results suggest that pan-Fos (an antibody that detects c-Fos, FosB, Fra-1 and Fra-2) results in a supershift, indicating the presence of Fos factors. Figure 7c shows that antibody speci®c for Fra-1 also produces a shift, suggesting that it may be a Fos component of the complex. A shifted band was also observed using a cJun speci®c antibody. JunD and JunB also produced a shift, although the bands were too faint to adequately reproduce. No shift was observed for Fra-2 or FosB (not shown).
Discussion
The DRR contains elements that control differentiation-dependent expression Epidermal gene expression is activated in a precise temporal and spatial manner during keratinocyte dierentiation ± speci®c genes are activated during early dierentiation, while other genes are expressed late. This sequential activation is functionally important. For example, proteins such as transglutaminase and involucrin, which are involved in the early stages of dierentiation, are expressed in the immediate suprabasal layers Rice and Green, 1979) , while loricrin, which is utilized late in dierentiation, is expressed later (Bickenbach et al., 1995; Hohl et al., 1991 Hohl et al., , 1993 . In spite of the importance in normal skin biology, the mechanisms that regulate gene expression during early versus late dierentiation are not well understood. However, it can be assumed that this regulation will involve input from multiple transcription factors, and that the composition of the regulatory complex may change during dierentiation. Numerous studies indicate that transcription factors and co-regulators function in complexes that, in Figure 5 Eect of AP1-5 site mutation on hINV expression in cervix and esophagus. Sections of cervix and esophagus were prepared from H6B, H6B(AP1 ± 5 mm), DRR or DRR(AP1 ± 5 mm) mice. The sections were prepared and incubated with primary and secondary antibodies as in Figure 2 . Similar staining was observed for three independent transgenic lines for each construct. EPI indicates the extent of the viable epithelial layer. The arrowheads in each panel indicate the position of basal epithelial layer turn, interact with the basal transcription machinery (Xiao et al., 2000; Xu et al., 1999; Chiang et al., 1993) . It could also be expected that multiple DNA binding sites may be involved, as this is frequently observed for regulation during dierentiation, and has been observed for involucrin (Banks et al., 1999; Welter et al., , 1996 .
Our previous studies identify a 520 nucleotide (nucleotides 72473/71953) region of the hINV upstream regulatory region, the DRR, as being necessary and sucient to drive dierentiation-appropriate gene expression in epidermis . The present experiments were designed to begin identifying the DNA sequence elements within the DRR that are required for expression at speci®c times during dierentiation. We approached this problem by dividing the DRR region into two separate segments and evaluating the ability of each to drive expression in transgenic mice. The results were revealing in that the upstream segment, DRR 72473/72100 , drives expression that is con®ned to the most highly dierentiated epidermal layers. In contrast, the downstream DRR segment, DRR 72100/71953 , does not drive transcription. However, DRR 72100/71953 clearly encodes DNA sequences that are necessary for appropriate expression during dierentiation, since eliminating this region results in a loss of expression during early dierentiation. Moreover, when DRR 72100/71953 is spliced in its appropriate position downstream of DRR 72473/72100 , expression during early dierentiation is restored. This result suggests that DRR 72100/71953 contains a transcription factor binding site(s) that is required, in conjunction with sites within DRR 72473/72100 , to confer a complete program of dierentiation-appropriate expression. A search of the DNA segment encoded in DRR 72100/71953 reveals several possible candidate sites that could mediate this regulation, and we are presently performing transgenic studies to identify a speci®c element within this region.
The AP1 site appears to be required for expression throughout differentiation
To identify transcription regulatory elements responsible for DRR 72473/72100 -dependent expression in late dierentiation, our strategy is to eliminate selected transcriptional elements within the upstream region of the DRR and then monitor the eects on expression of the transgene. AP1 factors are a family of transcription factors that are expressed in a wide variety of tissues and cells that function as homodimers of two Jun family proteins or as heterodimers of one Jun and one Fos family member. The Fos factors include c-Fos, FosB, FosB2, Fra-1 and Fra-2, while the Jun factors include c-Jun, JunB, and JunD (Suzuki et al., 1991; Nishina et al., 1990; . All of the known AP1 factors are expressed in both human and mouse epidermis, each displaying a speci®c pattern of dierentiation-dependent expression (Rutberg et al., 1996; Briata et al., 1993; Fisher et al., 1991) . Because the AP1-5 site has been speci®cally implicated as an important regulator of involucrin promoter activity in cultured cells (Takahashi et al., 1998; Takahashi and Iizuka, 1993; Banks et al., 1998 Banks et al., , 1999 E®mova and Eckert, 2000; Ng et al., 2000; E®mova et al., 1998) , we chose to evaluate its role as a dierentiation regulator. Our results show that mutation of the AP1-5 site results in markedly reduced expression at all stages of dierentiation. In addition to epidermis, this site must also be functionally important in other surface epithelia, as its inactivation results in a loss of expression in cervix and esophagus. Gel mobility supershift analysis using nuclear extracts from mouse epidermis shows that c-Jun, Fra-1, JunB, and JunD bind to the hINV AP1-5 element, all AP1 family members that are known to be expressed in mouse epidermis (Rutberg et al., 1996) . In nuclear extracts prepared from cultured human keratinocytes, this DNA sequence binds JunD, JunB and Fra-1 . This suggests that the regulation may be mediated by similar members of this family independent of species. These results are consistent with previous reports indicating a role for AP1 factors in expression of genes during keratinocyte dierentiation. Most of these studies have utilized in vitro cell culture models (DiSepio et al., 1995a; Casatorres et al., 1994; Bernerd et al., 1993; Hu et al., 1993; Lu et al., 1994; Medvedev et al., 1999; Rothnagel et al., 1993; Yamada et al., 1997) , although some have used transgenic mice (DiSepio et al., 1995b; reviewed in Eckert et al., 1997b) . (7) AP1-5 were prepared from back epidermis, footpad epidermis, esophageal epithelium, and kidney, were electrophoresed on a 6% polyacrylamide gel under denaturing conditions, and transferred to nitrocellulose membrane. hINV was detected by incubation with an hINV-speci®c primary antibody with secondary detection using a chemiluminescence. The arrows indicate hINV migration. The lane marked rhINV contains recombinant human involucrin, electrophoresed as a standard Figure 7 Gel mobility shift analysis of the AP1-5 site. (a) Nuclear extracts were prepared from mouse epidermis. The extracts were then incubated with 32 P-labeled double-stranded oligomer, 5'-TTAAGGCTCTTATTATGCCGTGAGTCAGAGGGCGGGAGG-CA-3', encoding the hINV AP1-5 binding site (bold) and¯anking sequence. Speci®city was demonstrated by including a 10-and 100-fold molar excess of homologous oligomer during the binding reaction. No competition was observed using a 100-fold molar excess of non-speci®c oligonucleotide. Complexes were separated by electrophoresis and visualized by autoradiography. Migration of the free probe (FP) and AP1-speci®c bands is indicated. (b) Nuclear extracts were incubated with oligonucleotide as in (a) and incubated with no antibody, non-speci®c antibody (anti-IgG), or an antibody that detects all fos proteins added for 1 h prior to electrophoresis. Migration of the shifted radioactive probe was visualized by autoradiography. (c) Nuclear extracts were incubated as in (b), except using antibodies speci®c for anti-c-jun, anti-Fra-1, or anti-IgG (non-speci®c control)
Based on these studies we propose a working model describing this regulation (Figure 8) . A previous in vivo study indicates that an AP1/SP1 interaction is required for optimal AP1 factor interaction at the AP1-5 site (Banks et al., 1998) . The AP1-5 and Sp1 sites are separated by a single nucleotide, and increasing this spacing or mutating the Sp1 site results in decreased AP1 factor binding at the AP1-5 site and decreased transcriptional activation (Banks et al., 1998) . For this reason, and based on our present results, we suggest that Sp1 and AP1 factor binding within the DRR 72473/ 72100 is required for in vivo expression ± presumably these events are essential for expression during late dierentiation, but are not adequate for expression early in dierentiation. For expression during early dierentiation, we suggest the requirement for a second element that is located within the DRR 72100/71953 segment. This element, or elements, binds to a presently unidenti®ed factor or complex that then participates, with the AP1/Sp1 complex, to drive the complete program of dierentiation-dependent expression. An alternate model would suggest that the DRR 72100/71953 element may function independently from the DRR 72473/72100 region. However, if this were the case, we would expect to see the DRR 72100/71953 transgene drive expression during early dierentiation, and this is not observed in our transgenic studies. We further postulate that this transcriptional complex then interacts with the basic transcription machinery to regulate expression. Experiments are underway to test this model and to identify the transcriptional regulatory element(s) within the downstream DRR.
Materials and methods
Construction of hINV transgenes
The H6B transgene is a 6 kb HindIII/BamHI fragment containing the complete hINV gene that was derived by restricting Charon 4AlI-3 with HindIII/BamHI and subcloning the resulting six kilobase fragment into HindIII/BamHIrestricted pSP64 to yield pSP64lI-3 H6B (Eckert and Green, 1986) . Constructs H6B, DRR-P3.4B and P3.4B were derived from this construct and have been previously described . To construct H6B(AP1 ± 5 mm), plasmid pINV-2473(AP1 ± 5 mm/Sp1), which contains the AP1-5 mutant site (Banks et al., 1998; , was digested with HindIII/KpnI. This fragment was used to replace the corresponding native sequence in pSP64lI-3 H6B to create H6B(AP1 ± 5 mm). The DRR-P3.4B(AP1 ± 5 mm) transgene was constructed by HindIII/BglII digestion of H6B(AP1 ± 5 mm) and subsequent subcloning of the HindIII/BglII fragment containing the AP1-5 mutation into HindIII/BglIIdigested DRR-P3.4B to create DRR-P3.4B(AP1 ± 5 mm). The DRR 72473/72100 -P3.4B and DRR 72100/71953 -P3.4B transgenes were constructed as follows. The DRR-P3.4B construct was digested with SphI/BglII, blunted with T4 DNA polymerase, and ligated to create DRR 72473/72100 -P3.4B. In parallel, DRR-P3.4B was digested with SphI, blunted, and digested with BglII. The released 147 bp hINV promoter fragment (72100/71953) was cloned into a BglII/SmaIrestricted pGL2-basic.. This plasmid, pGL2-DR 72100/71953 , was digested with HindIII/AccI and the released DRR 72100/ 71953 fragment was cloned to HindIII/AccI-digested P3.4B to create DRR 72100/71953 -P3.4B. For microinjection, the transgenes were released from plasmid sequences by restriction with HindIII/BamHI.
Production and identification of hINV gene-positive mice
Mouse embryos from a B6CBA6B6CBA mating were injected with each hINV gene construct and implanted into surrogate mothers as previously described . The ospring were characterized for the presence of the human involucrin (hINV) transgene by blotting of tail DNA.
Detection of hINV transgene expression
To detect hINV expression in mouse tissues, total protein extracts were prepared from tissue samples in Laemmli sample buer. The samples were electrophoresed on acrylamide gels and transferred to nitrocellulose for antibody-dependent detection of hINV. The blot was incubated with a primary antibody prepared against recombinant human involucrin (LaCelle et al., 1998) diluted 1 : 600, followed by visualization using a chemiluminescent detection system. To localize hINV expression, immunohistology was performed as previously described .
Nuclear extract preparation and gel mobility shift and supershift assays
Mouse epidermal extracts were prepared as previously described with slight modi®cation Fei et al., 1995) . All procedures were carried out at 48C. The back epidermis from an adult mouse was harvested by ®rst removing the hair and then scraping the epidermis from the dermis. Minced epidermis (400 mg) was homogenized in 5 ml of Buer A (0.6% Nonidet P-40, 150 mM NaCl, 10 mM Figure 8 Discrete elements are required for tissue-speci®c and dierentiation-appropriate hINV gene expression. The AP1-5 and Sp1 binding sites are located at adjacent locations in the DRR. These sites are occupied, respectively, by AP1 factors (c-Jun, Fra-1, JunB, and JunD in mouse ± Figure 7 ; JunB, JunD, and Fra-1 in humans ), and Sp1 (Banks et al., 1998) . Based on the present study, we suggest that an additional unknown element (or elements) is located within the DRR 72100/ 71953 segment. We postulate that factors binding to this region cooperate with the Sp1/AP1 factor complex to recruit additional factors to form an active transcriptional complex which then interacts with the basal transcription machinery. We suggest that this mechanism is responsible for activating appropriate expression during keratinocyte dierentiation HEPES pH 7.9, 1 mM EDTA, 0.5 mM PMSF) using type B pestle (Kontes). After 25 strokes the homogenate was centrifuged for 30 s at 2000 r.p.m. to remove tissue clumps. The supernatant was incubated for 5 min on ice and then centrifuged for 5 min at 5000 r.p.m. to collect the nuclei. The pelleted nuclei were extracted in 500 ml of solution B (25% glycerol, 20 mM HEPES pH 7.9, 420 mM NaCl, 1.2 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM PMSF, 2 mM benzamidine, and 5 mg/ml of pepstatin, leupeptin, and aprotinin) on ice for 20 min. The lysed nuclei were transferred to a microcentrifuge tube and cellular debris was pelleted by a 15 s centrifugation. The supernatant containing the DNA-binding proteins was then stored frozen in liquid nitrogen and stored at ± 808C.
For gel mobility shift assay, the reaction (20 ml) contained 15% glycerol, 75 mM KCl, 0.375 mM dithiothreitol, 0.375 mM phenylmethylsulfonyl¯uoride, 12.5 mM NaCl, 0.1 mg/ml poly(dl-dC), 2.5 mg of nuclear extract, and 0.3 ng radiolabeled DNA. The mixture was incubated for 15 min at room temperature and samples were immediately electrophoresed at 250 V for 2.5 h on a 5% nondenaturing acrylamide gel using 1/46TBE running buer. The gels were then dried for autoradiography. For competition studies, radioinert DNA competitor was added as a 10-or 100-fold molar excess. For gel supershift assays, the complete gel mobility shift assay mixture, without the 32 P-labeled oligonucleotide, was incubated at 48C for 2 h in the presence of a rabbit polyclonal antibodies, obtained from Santa Cruz, speci®c for pan-fos (sc-253), junD (sc-74), junB (sc-46), c-jun (sc-1694), Fra-1 (sc-605), Fra-2 (sc-171), and FosB (sc-48). The labeled oligonucleotide was then added and the reaction mixture incubated and electrophoresed as above.
